LSTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Landstar System Inc (LSTR) is not a strong buy for a beginner investor with a long-term focus at this moment. While the technical indicators suggest a bullish trend and hedge funds are significantly increasing their positions, the company's recent financial performance shows declining revenue, net income, and EPS. Additionally, analyst ratings are mixed, with no significant upgrades or strong buy recommendations. The options data and lack of recent news or political trading activity do not provide compelling evidence for immediate action. Considering the investor's preference for long-term growth and the current financial and market conditions, holding off on purchasing this stock is advisable.
The technical indicators show a bullish trend with the MACD histogram above 0 and positively contracting, RSI in the neutral zone at 69.589, and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level of R1: 173.359, with a pivot at 167.138.
Hedge funds are significantly increasing their positions, with a 22,885.24% increase in buying over the last quarter. Gross margin improved by 3.70% YoY in Q4 2025.
Declining financial performance in Q4 2025, with revenue down 2.94% YoY, net income down 48.17% YoY, and EPS down 46.56% YoY. Analyst ratings remain mixed, with no strong buy recommendations. Stock trend analysis suggests a potential short-term decline of -1.59% in the next day and -4.85% in the next week.
In Q4 2025, revenue dropped by 2.94% YoY to $1,177,534,000, net income declined by 48.17% YoY to $23,944,000, and EPS fell by 46.56% YoY to 0.7. However, gross margin increased by 3.70% YoY to 13.47%.
Analyst ratings are mixed. Stifel raised the price target to $147 but maintained a Hold rating. Evercore ISI raised the price target to $157 with an In Line rating, citing optimism about an EPS recovery. Baird raised the price target to $164 with an Outperform rating, while Truist lowered the price target to $145 with a Hold rating due to Q4 earnings miss.
